Avid Bioservices Inc (CDMO)

[realist1]

RE "Companies with a MC under $300mm 0 for 15 in Phase III oncology trials - just coincidence my man?"

Your point is completely valid. It's not some statistical oddity.
There's a sensible logic behind it. Basically word ALWAYS slips out, and that moves the stocks the direction of the outcome. Under $300 million obviously the market knows the trial will fail.

I'm NOT calling for that YET (maybe later) for Sunrise - there's still time, but unfortunately I have zero confidence in PPHM doing what it takes to turn the stock trend. They simply do not learn from past mistakes.

Will shareholders wake them up? Let's hope so.